Will Pfizer's RSV vaccine, Abrysvo, be recommended by the CDC for immunocompromised adults by March 31, 2025? | Binary | | | 4 months ago | |
Will the CDC recommend RSV vaccination for all adults aged 18+ by end of 2025? | Binary | | | 2 months ago | |
Will Pfizer's Abrysvo be the leading RSV vaccine by market share by June 30, 2025? | Binary | | | 2 months ago | |
Will Pfizer announce commercial availability of its RSV vaccine, Abrysvo, for immunocompromised adults by June 30, 2025? | Binary | | | 4 months ago | |
What will be Pfizer's RSV vaccine, Abrysvo, sales revenue in the first year of commercial availability by December 31, 2025? | Categorical | | | 4 months ago | |
Which country will be the first to approve Pfizer's RSV vaccine, Abrysvo, for immunocompromised adults by December 31, 2024? | Categorical | | | 4 months ago | |
Will Pfizer's RSV vaccine Abrysvo be included in CDC's recommended vaccines for immunocompromised adults by June 30, 2025? | Binary | | | 4 months ago | |
Will Pfizer's RSV vaccine Abrysvo be included in CDC's recommended vaccination schedule by mid-2025? | Binary | | | 4 months ago | |
What will be Pfizer's RSV vaccine Abrysvo sales revenue for fiscal year 2025? | Categorical | | | 4 months ago | |
Which company will lead in RSV vaccine market share by end of 2025? | Categorical | | | 2 months ago | |
Which major pharmaceutical company will announce new RSV vaccine development by end of 2025? | Categorical | | | 2 months ago | |
How many US states will adopt CDC's pneumococcal vaccine recommendation for adults 50+ by end of 2025? | Categorical | | | 2 months ago | |
Will any US state declare a state of emergency due to RSV by March 31, 2025? | Binary | | | 2 months ago | |
Will Pfizer's RSV vaccine, Abrysvo, receive FDA approval for use in immunocompromised adults by December 31, 2024? | Binary | | | 4 months ago | |
How many countries will approve Pfizer's RSV vaccine, Abrysvo, for immunocompromised adults by December 31, 2025? | Categorical | | | 4 months ago | |
What will be the impact of Pfizer's RSV vaccine Abrysvo on hospitalizations due to RSV in immunocompromised adults by December 31, 2025? | Categorical | | | 4 months ago | |
How many doses of Pfizer's RSV vaccine Abrysvo will be administered to immunocompromised adults in the US by December 31, 2025? | Categorical | | | 4 months ago | |
What will be the market share of Pfizer's RSV vaccine Abrysvo for immunocompromised adults by December 31, 2025? | Categorical | | | 4 months ago | |
Will Pfizer's RSV vaccine Abrysvo become commercially available in the US by March 31, 2025? | Binary | | | 4 months ago | |
Will Pfizer's RSV vaccine Abrysvo receive FDA approval for immunocompromised adults by December 31, 2024? | Binary | | | 4 months ago | |
Will Pfizer's RSV vaccine Abrysvo get FDA approval for immunocompromised adults by end of 2024? | Binary | | | 4 months ago | |
Will Pfizer's RSV vaccine Abrysvo receive a positive recommendation from ACIP by end of Q1 2025? | Binary | | | 4 months ago | |
Which major country will be the first to approve Pfizer's RSV vaccine Abrysvo after the US by mid-2025? | Categorical | | | 4 months ago | |
Which RSV vaccine will have the largest market share in the US by end of 2025? | Categorical | | | 4 months ago | |
